证券代码：603155 证券简称：新亚强 公告编号：2023-042 新亚强硅化学股份有限公司 关于公司 2023 年半度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 经中国证券监督管理委员会《关于核准新亚强硅化学股份有限公司首次公开 发行股票的批复》（证监许可[2020]1589 号）核准，公司于上海证券交易所向社 会公众公开发行人民币普通股（A 股）股票 3,889 万股，每股面值为人民币 1.00 元，每股发行价格为人民币 31.85 元，募集资金总额为人民币 1,238,646,500.00 元，扣除与本 次发 行相关的费用 38,646,500.00 元后，募集 资金净额为 1,200,000,000.00 元，上述资金于 2020 年 8 月 26 日全部到账。瑞华会计师事务 所（特殊普通合伙）对募集资金到账情况进了审验，并出具了瑞华验字 [2020]91010001 号《验资报告》。 （二）募集资金使用金额及当前余 ...

证券代码：603155 证券简称：新亚强 公告编号：2023-039 新亚强硅化学股份有限公司 第三届董事会第十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 新亚强硅化学股份有限公司（以下简称"公司"）第三届董事会第十次会议 通知于 2023 年 8 月 11 日以电子邮件及专人送达的方式发出，会议于 2023 年 8 月 22 日在公司会议室以现场和通讯相结合的方式召开。本次会议应出席董事 6 人，实际出席董事 6 人，会议由董事长初亚军先生主持，公司监事及部分高级管 理人员列席会议。本次会议的召集、召开符合《公司法》等有关法律、法规及《公 司章程》的规定。 二、董事会会议审议情况 （一）审议通过了《关于 2023 年半年度报告及其摘要的议案》 一、董事会会议召开情况 表决结果：6 票同意；0 票反对；0 票弃权。 特此公告。 新亚强硅化学股份有限公司董事会 2022 年 8 月 23 日 具体内容详见公司于 2023 年 8 月 23 日披露于上海证券交易所网站上的 《2023 年半年报报告》《20 ...

证券代码：603155 证券简称：新亚强 公告编号：2023-043 新亚强硅化学股份有限公司 关于 2023 年半年度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上海证券交易所上市公司自律监管指引第 3 号—行业信息披露》及相 关要求，新亚强硅化学股份有限公司（以下简称"公司"）现将 2023 年半年度 主要经营数据披露如下： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 2023 | 年 1-6 | 月产量 | 2023 年 | 1-6 | 月销量 | 2023 年 | 1-6 | 月销售金 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | （吨） | | （吨） | | | 额（万元） | | | | 功能性助剂 | | 4,314.20 | | 4,254.35 | | | 27,039.94 | | | | 苯基氯硅烷 | | 2,128.33 | | 1,264.44 | | | ...

二、监事会会议审议情况 （一）审议通过了《关于 2023 年半年度报告及其摘要的议案》 监事会认为：公司 2023 年半年度报告及摘要的编制和审议程序符合法律、 法规及《公司章程》的有关规定；2023 年半年度报告及摘要的内容和格式符合 中国证监会和上海证券交易所的各项规定，所包含的信息真实地反映报告期内的 经营和财务状况；未发现参与编制和审议的人员有违反保密规定的行为。 表决结果：3 票同意；0 票反对；0 票弃权。 证券代码：603155 证券简称：新亚强 公告编号：2023-040 新亚强硅化学股份有限公司 第三届监事会第十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 新亚强硅化学股份有限公司（以下简称"公司"）第三届监事会第十次会议 通知于 2023 年 8 月 11 日以电子邮件及专人送达的方式发出，会议于 2023 年 8 月 22 日在公司会议室以现场及通讯相结合方式召开。本次会议应出席监事 3 人， 实际出席监事 3 人，会议由监事会主席刘贤钊先生主持。本次会议的 ...

证券代码：603155 证券简称：新亚强 公告编号：2023-038 会议召开时间：2023 年 8 月 23 日(星期三) 14:00-15:00 新亚强硅化学股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会 议 召 开 地 点 ： 上海证券 交易所上证路演中心（ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 8 月 16 日(星期三) 至 8 月 22 日(星期二)16:00 前登录 上 证 路 演 中 心 网 站 首 页 点 击 " 提 问 预 征 集 " 栏 目 或 通 过 公司邮箱 ir@newasiaman.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 新亚强硅化学股份有限公司（以下简称"公司"）将于 2023 年 8 月 23 日发 布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半 年 ...

2023 年第一季度报告 证券代码：603155 证券简称：新亚强 新亚强硅化学股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 1、公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2、公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财 务信息的真实、准确、完整。 3、第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 （一）主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | | 本报告期比上年同期增减 | | | --- | --- | --- | --- | --- | | | | | 变动幅度(%) | | | 营业收入 | | 226,715,678.12 | | -31.12 | | 归属于上市公司股东的净利润 | | 54,899,215.85 | | -42.59 | | 归属于上市公司股东的扣除非经常 ...

Financial Performance - The company's operating revenue for 2022 was CNY 1,133,598,652.44, representing a 28.82% increase compared to CNY 879,996,006.51 in 2021[22] - The net profit attributable to shareholders for 2022 was CNY 301,717,038.19, a decrease of 5.55% from CNY 319,444,551.13 in the previous year[22] - The net profit after deducting non-recurring gains and losses was CNY 284,406,514.11, down 2.39% from CNY 291,373,246.30 in 2021[22] - The net cash flow from operating activities increased by 57.50% to CNY 299,988,969.57, compared to CNY 190,468,110.19 in 2021[22] - The proposed cash dividend is CNY 10.00 per 10 shares, totaling CNY 225,562,000.00, along with a capital reserve conversion of 4 shares for every 10 shares held[6] - The company achieved significant production efficiency improvements and product quality enhancements through ongoing process optimization and technological innovation[34] - The company achieved operating revenue of CNY 1,133,598,652.44, an increase of 28.82% compared to the previous year[43] - Operating costs rose to CNY 785,392,756.44, reflecting a significant increase of 56.39% year-on-year, primarily due to rising raw material prices and increased production volume[45] - The company’s total assets reached CNY 2,705,163,800, a 7.97% increase from the previous year, and net assets attributable to shareholders increased by 6.64% to CNY 2,346,594,900[43] Research and Development - Research and development expenses increased by 30.89% to CNY 36,856,352.18, indicating a commitment to innovation and product development[44] - The company has established a long-term partnership with universities and research institutions, enhancing its R&D capabilities and innovation potential[41] - The company is focusing on R&D innovation to maintain its competitive edge in the organic silicon market[68] - The Shanghai R&D center has entered the installation and commissioning phase, while project design work at the Hubei facility is progressing smoothly[33] Market Expansion and Strategy - The company is actively expanding into new markets such as new energy vehicles, pharmaceuticals, and electronics, leveraging its core products' leading position in niche markets[33] - The company is accelerating the construction of projects, including a 10,000-ton annual production capacity for phenyl chlorosilane and a 2,500-ton annual production capacity for phenyl intermediates[34] - The company is optimizing its product line to meet the growing market demand in sectors such as organic silicon new materials, pharmaceuticals, and electronic chemicals[80] - The company is exploring potential mergers and acquisitions to strengthen its market position[175] Governance and Compliance - The company has established a governance structure that includes a general meeting of shareholders, a board of directors, a supervisory board, and management, ensuring clear responsibilities and checks and balances among these entities[95] - The board of directors consists of 6 members, with 3 independent directors, meeting the legal requirements and ensuring fair and effective decision-making[97] - The company has strengthened its information disclosure management, ensuring timely and accurate communication of relevant information to all shareholders[98] - The company has not faced any requests for a temporary shareholders' meeting from shareholders holding more than 10% of voting shares during the reporting period[95] Environmental and Safety Measures - The company emphasizes safety in its production processes, having achieved secondary certification for safety production standards, but acknowledges the inherent risks associated with handling hazardous chemicals[91] - Environmental protection measures are in place, including ISO 14001:2015 certification, but the company may face increased costs and regulatory challenges in the future[92] - The company invested approximately 27.99 million yuan in environmental protection during the reporting period[134] - The company has established a wastewater treatment system that complies with discharge standards, utilizing MVR evaporation and biochemical treatment processes[136] Shareholder Information - The total number of shares held by the top ten shareholders is 116,670,000, with significant increases in holdings for several key shareholders[199] - The largest shareholder, 初琳, holds 103,725,189 shares, representing 45.99% of the total shares[199] - The company plans to lift restrictions on shares for several shareholders on September 1, 2023[195] - The total number of ordinary shareholders increased from 13,137 to 14,151 during the reporting period[196] Financial Management - The company has engaged in entrusted financial management with a total amount of 220,951,000 RMB from self-owned funds and 178,000,000 RMB from raised funds[172] - The company has received returns from various entrusted financial management projects, with annualized yields ranging from 1.85% to 3.35%[172] - The company has maintained a good credit status with no defaults on court judgments or significant overdue debts[168] Risks and Challenges - The company faces risks from intensified market competition as domestic and international players expand their presence in the silicone market, potentially leading to price declines[90] - Macroeconomic fluctuations may impact the company's operations, as its business is closely tied to various downstream industries, which could affect customer demand[90]

证券代码：603155 证券简称：新亚强 公告编号：2023-006 新亚强硅化学股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会议召开时间：2023 年 4 月 27 日(星期四) 15:00-16:00 会 议 召 开 地 点 ： 上海证券 交易所上证路演中心（ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 4 月 20 日(星期四) 至 4 月 26 日（星期三）16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过 公司邮箱 ir@newasiaman.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 新亚强硅化学股份有限公司（以下简称"公司"）将于 2023 年 4 月 25 日发 布公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营 成果、财务状况，公司计划于 2023 年 4 月 2 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥275,216,940.24, representing a 25.68% increase compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2022 was ¥73,608,275.59, showing a decrease of 10.88% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥69,101,543.48, down by 9.00% compared to the previous year[3]. - The basic earnings per share for Q3 2022 was ¥0.33, a decrease of 10.81% compared to the same period last year[3]. - The net profit for Q3 2022 was CNY 264,742,592.84, an increase of 15.4% compared to CNY 229,355,399.95 in Q3 2021[19]. - The total comprehensive income for Q3 2022 was CNY 264,742,592.84, an increase from CNY 229,355,399.95 in Q3 2021, representing a growth of 15.4%[20]. - Net profit for the first three quarters of 2022 was ¥264,289,219.25, up 15.2% from ¥229,355,399.95 in the previous year[30]. Revenue and Costs - Total operating revenue for the first three quarters of 2022 reached RMB 940,585,075.66, a significant increase from RMB 633,377,672.84 in the same period of 2021, representing a growth of approximately 48.4%[18]. - Total operating costs for the first three quarters of 2022 were RMB 666,842,810.04, compared to RMB 402,619,339.76 in the first three quarters of 2021, indicating an increase of about 65.7%[18]. - The total revenue for the first three quarters of 2022 reached ¥940,578,279.27, a significant increase of 48.4% compared to ¥633,377,672.84 in the same period of 2021[29]. Cash Flow - The cash flow from operating activities for the year-to-date period reached ¥256,423,754.46, an increase of 97.85%[3]. - The cash flow from operating activities for the first three quarters of 2022 was CNY 256,423,754.46, significantly higher than CNY 129,608,275.50 in the same period of 2021, marking a growth of 97.9%[22]. - The cash flow from investing activities showed a net inflow of CNY 38,903,485.43 in Q3 2022, a recovery from a net outflow of CNY -207,863,706.39 in Q3 2021[23]. - The net cash flow from operating activities for the first three quarters of 2022 was approximately ¥256.49 million, a 98% increase compared to ¥129.61 million in the same period of 2021[32]. - The net cash flow from investment activities for Q3 2022 was approximately ¥20.72 million, a significant improvement from a negative cash flow of ¥207.86 million in Q3 2021[33]. Assets and Liabilities - The total assets at the end of Q3 2022 were ¥2,707,557,913.27, an increase of 8.07% from the end of the previous year[4]. - Total assets as of September 30, 2022, were RMB 2,707,557,913.27, up from RMB 2,505,486,058.34 at the end of 2021, representing an increase of approximately 8.1%[15]. - Total liabilities as of September 30, 2022, were RMB 367,937,438.98, compared to RMB 305,048,176.89 at the end of 2021, indicating an increase of about 20.7%[14]. - The total liabilities as of September 30, 2022, were ¥367,908,796.97, compared to ¥305,043,169.84 at the end of 2021, indicating an increase of 20.6%[27]. Shareholder Information - The company had a total of 15,243 common shareholders at the end of the reporting period[8]. - The top shareholder, Chulin, held 45.99% of the shares, totaling 103,725,189 shares[9]. Research and Development - Research and development expenses for the first three quarters of 2022 amounted to RMB 26,084,397.73, up from RMB 19,532,144.91 in the same period of 2021, reflecting a growth of approximately 33.4%[18]. - Research and development expenses for the first three quarters of 2022 were ¥26,084,397.73, up 33.4% from ¥19,532,144.91 in 2021, highlighting a commitment to innovation[29]. Future Strategies - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the provided content[18]. - The company has plans for future growth strategies, including potential mergers and acquisitions, although specific details were not provided in the content[18].

[Definitions](index=4&type=section&id=Item%201.%20Definitions) This section provides definitions of key terms used in the report [Company Profile and Key Financial Indicators](index=4&type=section&id=Item%202.%20Company%20Profile%20and%20Key%20Financial%20Indicators) This section provides an overview of the company's basic information and key financial performance metrics [Company Basic Information](index=4&type=section&id=I.%20Company%20Information) Xinyaqiang Silicon Chemical Co., Ltd. (Xinyaqiang) specializes in the R&D, production, and sales of organosilicon fine chemicals, with Chu Yajun as its legal representative, and its registered address changed during the reporting period - The company's Chinese name is Xinyaqiang Silicon Chemical Co., Ltd., stock code **603155**, listed on the Shanghai Stock Exchange[11](index=11&type=chunk)[16](index=16&type=chunk) - During the reporting period, the company's registered address changed from 'No. 3 Jingwu Road, Suqian Ecological Chemical Industry Park' to 'No. 2 Yangzi Road, Suqian Ecological Chemical Industry Park'[13](index=13&type=chunk) [Key Accounting Data and Financial Indicators](index=5&type=section&id=VII.%20Key%20Accounting%20Data%20and%20Financial%20Indicators) In the first half of 2022, the company achieved strong performance growth, with revenue increasing by **60.56%** to **665.37 million Yuan** and net profit attributable to shareholders rising by **30.23%** to **191.12 million Yuan**, driven by higher product prices and sales volumes Key Accounting Data for H1 2022 | Key Accounting Data | Current Period (Jan-Jun) (Yuan) | Prior Period (Yuan) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 665,368,135.42 | 414,393,998.89 | 60.56 | | Net Profit Attributable to Listed Company Shareholders | 191,120,801.78 | 146,757,676.14 | 30.23 | | Net Profit Attributable to Listed Company Shareholders (Excluding Non-recurring Items) | 179,524,620.74 | 132,608,674.55 | 35.38 | | Net Cash Flow from Operating Activities | 193,256,420.35 | 59,681,746.53 | 223.81 | | **Indicator** | **Current Period End (Yuan)** | **Prior Year End (Yuan)** | **YoY Change (%)** | | Net Assets Attributable to Listed Company Shareholders | 2,235,998,683.23 | 2,200,437,881.45 | 1.62 | | Total Assets | 2,633,812,405.96 | 2,505,486,058.34 | 5.12 | Key Financial Indicators for H1 2022 | Key Financial Indicators | Current Period (Jan-Jun) | Prior Period | Change | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (Yuan/share) | 0.85 | 0.65 | Growth 30.77% | | Basic Earnings Per Share (Excluding Non-recurring Items) (Yuan/share) | 0.80 | 0.59 | Growth 35.59% | | Weighted Average Return on Net Assets (%) | 8.52 | 7.19 | Increase 1.33 percentage points | | Weighted Average Return on Net Assets (Excluding Non-recurring Items) (%) | 8.00 | 6.50 | Increase 1.50 percentage points | - The growth in the company's revenue and profit indicators is primarily attributed to the increase in product prices and sales volumes during the reporting period[20](index=20&type=chunk) [Non-recurring Gains and Losses](index=6&type=section&id=IX.%20Non-recurring%20Gains%20and%20Losses%20and%20Amounts) In the first half of 2022, the company's total non-recurring gains and losses amounted to **11.60 million Yuan**, primarily driven by fair value changes and investment income from financial assets totaling **13.52 million Yuan** Details of Non-recurring Gains and Losses | Non-recurring Item | Amount (Yuan) | | :--- | :--- | | Non-current asset disposal gains and losses | -136,619.63 | | Government grants recognized in current profit or loss | 1,170,586.02 | | Fair value changes and investment income from trading financial assets, etc | 13,519,422.35 | | Other non-operating income and expenses | -1,000,000.00 | | Other non-recurring items as defined | 136,119.37 | | **Less: Income tax impact** | **2,093,327.07** | | **Total** | **11,596,181.04** | [Management Discussion and Analysis](index=7&type=section&id=Item%203.%20Management%20Discussion%20and%20Analysis) This section provides an in-depth analysis of the company's operations, financial condition, and future outlook [Industry and Main Business](index=7&type=section&id=I.%20Description%20of%20Industry%20and%20Main%20Business%20during%20the%20Reporting%20Period) The company specializes in the R&D, production, and sales of organosilicon fine chemicals, primarily offering organosilicon functional additives and phenylchlorosilanes for various industries including new materials, pharmaceuticals, and electronics - The company's main business is organosilicon fine chemicals, with products categorized into organosilicon functional additives and phenylchlorosilanes[24](index=24&type=chunk) - Functional additive products include methyl series (hexamethyldisilazane, silyl ether) and vinyl series (vinyl disilazane), serving as key materials for silicone rubber, pharmaceutical synthesis, semiconductor industry, and lithium battery electrolytes[25](index=25&type=chunk) - Phenylchlorosilane products are crucial raw materials for producing special organosilicon materials like phenyl silicone rubber, silicone resin, and silicone oil, which exhibit excellent performance in high/low temperature resistance and radiation resistance[25](index=25&type=chunk) [Core Competencies](index=7&type=section&id=II.%20Analysis%20of%20Core%20Competencies%20during%20the%20Reporting%20Period) The company's core competencies include advanced processes, comprehensive product services, strong R&D innovation, integrated industrial chain, and a reputable market brand, with leading domestic market share and patented technologies - The company possesses self-developed core patented technologies, including solvent-free hexamethyldisilazane, new vinyl special monomers, and direct phenylchlorosilane production, ensuring outstanding product quality and leading domestic market share and export volume[26](index=26&type=chunk) - The company provides multi-variety product portfolio solutions tailored to customer needs, fostering long-term and stable client relationships[27](index=27&type=chunk) - The company has established multiple provincial R&D centers, collaborates with universities for industry-academia-research initiatives, holds **47 patents**, and its hexamethyldisilazane product is recognized as a manufacturing single champion product[27](index=27&type=chunk) - The company continuously extends its organosilicon industry chain upstream and downstream, enhances comprehensive utilization of by-products, builds a circular economy, and improves profitability and market competitiveness[28](index=28&type=chunk) [Discussion and Analysis of Operations](index=8&type=section&id=III.%20Discussion%20and%20Analysis%20of%20Operations) In H1 2022, the company maintained steady growth in key operating indicators, with revenue reaching **665.37 million Yuan** and net profit **191.12 million Yuan**, while new projects like the 10,000-ton phenylchlorosilane (Phase II) facility successfully commenced operations - During the reporting period, the company overcame adverse impacts such as the pandemic, rising raw material, and logistics costs, maintaining steady growth in key operating indicators[29](index=29&type=chunk) - Progress was made in the company's new project construction, with the successful commissioning of the **10,000-ton/year** phenylchlorosilane (Phase II) and **2,500-ton/year** phenyl intermediate projects, solidifying the company's advantageous position in the organosilicon sub-segment[29](index=29&type=chunk) Key Performance Indicators for H1 2022 | Indicator | Amount (10,000 Yuan) | YoY Growth (%) | | :--- | :--- | :--- | | Operating Revenue | 66,536.81 | 60.56 | | Net Profit Attributable to Listed Company Shareholders | 19,112.08 | 30.23 | | Net Profit Attributable to Listed Company Shareholders (Excluding Non-recurring Items) | 17,952.46 | 35.38 | | Earnings Per Share (Yuan) | 0.85 | 30.77 | [Main Business Analysis](index=9&type=section&id=(I)%20Main%20Business%20Analysis) During the reporting period, the company's main business revenue increased by **60.56%** due to higher product prices and sales, while operating costs rose by **87.34%** due to increased raw material and logistics expenses, and financial expenses significantly decreased due to exchange gains Analysis of Major Financial Statement Items | Item | Current Period Amount (Yuan) | Prior Period Amount (Yuan) | Change (%) | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 665,368,135.42 | 414,393,998.89 | 60.56 | Increase in product prices and sales volumes | | Operating Cost | 449,223,947.05 | 239,789,563.40 | 87.34 | Increase in raw material prices and logistics costs | | Financial Expenses | -12,728,969.43 | 234,157.41 | -5,536.07 | Exchange gains | | Net Cash Flow from Operating Activities | 193,256,420.35 | 59,681,746.53 | 223.81 | Increase in cash received from sales of goods | [Analysis of Assets and Liabilities](index=9&type=section&id=(III)%20Analysis%20of%20Assets%20and%20Liabilities) As of the end of the reporting period, total assets were **2.63 billion Yuan**, with cash increasing by **48.49%** due to redemption of financial assets, and construction in progress rising by **53.95%** due to ongoing project investments Changes in Major Assets and Liabilities | Item Name | Current Period End Amount (Yuan) | Prior Year End Amount (Yuan) | Change (%) | Explanation | | :--- | :--- | :--- | :--- | :--- | | Cash and Bank Balances | 351,305,891.11 | 236,578,797.47 | 48.49 | Primarily due to redemption of trading financial assets | | Construction in Progress | 168,086,726.17 | 109,182,691.54 | 53.95 | Primarily due to increased investment in ongoing projects during the period | | Short-term Borrowings | 13,300,000.00 | 0.00 | 100.00 | Primarily due to increased bank borrowings during the period | | Contract Liabilities | 3,793,481.00 | 6,632,371.78 | -42.80 | Primarily due to decrease in advance receipts during the period | [Analysis of Investment Status](index=10&type=section&id=(IV)%20Analysis%20of%20Investment%20Status) During the reporting period, the company's external equity investments totaled **107 million Yuan**, a **100%** increase, including a planned **400 million Yuan** joint venture with Hubei Xingrui Silicon Material Co., Ltd., which is yet to be established - The company plans to invest **400 million Yuan** to establish a joint venture with Hubei Xingrui Silicon Material Co., Ltd. to expand its business layout[38](index=38&type=chunk) - As of June 30, 2022, the company's financial assets measured at fair value totaled **1.25 billion Yuan**, primarily comprising trading financial assets and accounts receivable financing[40](index=40&type=chunk) [Analysis of Major Holding and Participating Companies](index=11&type=section&id=(VI)%20Analysis%20of%20Major%20Holding%20and%20Participating%20Companies) The company's main wholly-owned subsidiary, Xinyaqiang (Shanghai) Silicon Material Co., Ltd., engaged in R&D and trade, reported a net profit of **0.27 million Yuan** during the period Key Financial Data of Xinyaqiang (Shanghai) Silicon Material Co., Ltd. (Unit: 10,000 Yuan) | Total Assets | Net Assets | Operating Revenue | Net Profit | | :--- | :--- | :--- | :--- | | 12,051.29 | 12,027.22 | 14.16 | 26.53 | [Risk Warnings](index=11&type=section&id=(I)%20Potential%20Risks) The company faces risks including intensified market competition, macroeconomic and market environment changes, safety production, environmental protection, technological R&D, and significant international environment shifts - Risk of intensified market competition: Entry of dominant industry players into the company's key product segments may lead to capacity expansion and price declines[43](index=43&type=chunk) - Safety production and environmental risks: The company's production involves hazardous chemicals, posing potential safety accidents; stricter environmental regulations may increase operating costs[44](index=44&type=chunk) - Technology R&D risk: New product development involves long cycles and high costs, and failure to develop or adapt to market demand could adversely affect operations[45](index=45&type=chunk) - Risk of significant international environmental changes: Recurring global pandemics and geopolitical conflicts may lead to rising commodity prices, disrupted international logistics, and significant exchange rate fluctuations[46](index=46&type=chunk) [Corporate Governance](index=12&type=section&id=Item%204.%20Corporate%20Governance) This section details changes in the company's board, supervisors, and senior management, as well as its profit distribution plan [Changes in Directors, Supervisors, and Senior Management](index=12&type=section&id=II.%20Changes%20in%20the%20Company's%20Directors%2C%20Supervisors%2C%20and%20Senior%20Management) During the reporting period, the company's director and deputy general manager, Mr. Chu Yaxian, passed away, leading to changes in the board and senior management - Mr. Chu Yaxian, former director and deputy general manager, resigned due to illness and passing[49](index=49&type=chunk)[50](index=50&type=chunk) [Profit Distribution Plan](index=13&type=section&id=III.%20Profit%20Distribution%20or%20Capital%20Reserve%20to%20Share%20Capital%20Plan) The company proposes no profit distribution or capital reserve capitalization for the first half of 2022 - The H1 2022 profit distribution plan proposes no distribution and no capitalization from capital reserves[51](index=51&type=chunk) [Environmental and Social Responsibility](index=13&type=section&id=Item%205.%20Environmental%20and%20Social%20Responsibility) This section outlines the company's environmental protection measures and its contributions to social welfare initiatives [Environmental Information](index=13&type=section&id=(I)%20Environmental%20Information%20for%20Companies%20and%20Major%20Subsidiaries%20Designated%20as%20Key%20Pollution%20Units%20by%20Environmental%20Protection%20Authorities) As a key pollution unit, the company operates wastewater treatment and incineration facilities, adheres to environmental regulations, and reported no excessive emissions or administrative penalties during the period - The company has established wastewater treatment systems and incineration facilities for waste gas, liquid, and residue, ensuring all emissions meet standards after treatment[55](index=55&type=chunk) - The company strictly implements environmental impact assessment and the 'three simultaneous' system, and has filed its 'Emergency Plan for Environmental Incidents' with environmental authorities[56](index=56&type=chunk)[57](index=57&type=chunk) - During the reporting period, the company received no administrative penalties for environmental issues[59](index=59&type=chunk) [Social Responsibility](index=15&type=section&id=II.%20Specific%20Information%20on%20Consolidating%20Poverty%20Alleviation%20Achievements%20and%20Rural%20Revitalization) During the reporting period, the company actively fulfilled its social responsibilities by donating **1 million Yuan** for epidemic prevention and contributing books to local community libraries - In April 2022, the company donated **1 million Yuan** for epidemic prevention to Jilin City[60](index=60&type=chunk) - In June 2022, the company donated books to Yubei Community to support the construction of local rural libraries[60](index=60&type=chunk) [Significant Matters](index=16&type=section&id=Item%206.%20Significant%20Matters) This section details the fulfillment of commitments made by the company and its related parties during the initial public offering [Fulfillment of Commitments](index=16&type=section&id=I.%20Fulfillment%20of%20Commitments) During the reporting period, the company's actual controllers, shareholders, and D&O strictly fulfilled their commitments made during the IPO, including share lock-up, reduction intentions, and share price stabilization plans - The company's controlling shareholder, actual controllers, shareholders holding **5%** or more, and D&O have strictly fulfilled their share lock-up commitments since the company's listing on September 1, 2020, with a lock-up period of **36 months**[63](index=63&type=chunk)[64](index=64&type=chunk)[65](index=65&type=chunk)[68](index=68&type=chunk)[70](index=70&type=chunk)[71](index=71&type=chunk) - The company, its actual controllers, and D&O have formulated a share price stabilization plan for the three years post-listing, to be activated if the share price falls below net asset value per share, including company buybacks, and increased holdings by actual controllers and D&O[74](index=74&type=chunk)[75](index=75&type=chunk)[76](index=76&type=chunk)[77](index=77&type=chunk)[78](index=78&type=chunk) [Share Changes and Shareholder Information](index=25&type=section&id=Item%207.%20Share%20Changes%20and%20Shareholder%20Information) This section provides details on changes in the company's share capital, shareholder structure, and changes in controlling shareholders or actual controllers [Share Capital Changes](index=25&type=section&id=I.%20Share%20Capital%20Changes) During the reporting period, the company's total share capital increased from **155.56 million** shares to **225.56 million** shares due to a capital reserve capitalization plan of **4.5** shares for every **10** shares - The company implemented a capital reserve capitalization plan of **4.5** shares for every **10** shares, increasing total share capital from **155,560,000** shares to **225,562,000** shares[92](index=92&type=chunk)[93](index=93&type=chunk) [Shareholder Information](index=27&type=section&id=II.%20Shareholder%20Information) As of the reporting period end, the company had **15,458** common shareholders, with Chu Lin (**45.99%**) and Hongta Innovation (Kunshan) Venture Capital Co., Ltd. (**12.63%**) as the top two shareholders - As of the end of the reporting period, the company had a total of **15,458** shareholders[97](index=97&type=chunk) Top Ten Shareholders' Shareholding | Shareholder Name | Shares Held at Period End (shares) | Proportion (%) | Nature of Shares | | :--- | :--- | :--- | :--- | | Chu Lin | 103,725,189 | 45.99 | Domestic Natural Person | | Hongta Innovation (Kunshan) Venture Capital Co., Ltd. | 28,482,799 | 12.63 | State-owned Legal Person | | Hongta Innovation Investment Co., Ltd. | 16,377,445 | 7.26 | State-owned Legal Person | | Sun Xiujie | 14,241,403 | 6.31 | Domestic Natural Person | | Huaxia Life Insurance Co., Ltd. - Proprietary Funds | 5,851,765 | 2.59 | Unknown | | National Social Security Fund 503 Portfolio | 5,399,995 | 2.39 | Unknown | | Chu Yajun | 3,444,664 | 1.53 | Domestic Natural Person | [Change in Controlling Shareholder or Actual Controller](index=30&type=section&id=IV.%20Change%20in%20Controlling%20Shareholder%20or%20Actual%20Controller) The company's actual controllers changed on June 7, 2022, with Ms. Sun Xiujie inheriting shares from the deceased Mr. Chu Yaxian, dissolving the previous concerted action relationship, and establishing Chu Lin as the controlling shareholder, and Chu Yajun and Chu Lin as the actual controllers - The company's actual controllers changed on **June 7, 2022**, with the new actual controllers being Chu Yajun and Chu Lin[106](index=106&type=chunk) [Preferred Shares Information](index=30&type=section&id=Item%208.%20Preferred%20Shares%20Information) This section confirms that the company has no preferred shares during the reporting period [Preferred Shares](index=30&type=section&id=Item%208.%20Preferred%20Shares%20Information) The company has no preferred shares during the reporting period - Not applicable[108](index=108&type=chunk) [Bonds Information](index=30&type=section&id=Item%209.%20Bonds%20Information) This section confirms that the company has no bond-related information during the reporting period [Bonds](index=30&type=section&id=Item%209.%20Bonds%20Information) The company has no corporate bonds, company bonds, non-financial enterprise debt financing instruments, or convertible bonds during the reporting period - Not applicable[109](index=109&type=chunk)[110](index=110&type=chunk) [Financial Report](index=32&type=section&id=Item%2010.%20Financial%20Report) This section presents the company's unaudited financial statements, including key balance sheet, income statement, and cash flow data for the reporting period [Financial Statement Overview](index=32&type=section&id=II.%20Financial%20Statements) This semi-annual report's financial statements are unaudited; as of June 30, 2022, total assets were **2.63 billion Yuan**, owner's equity **2.24 billion Yuan**, with H1 2022 total revenue **665.37 million Yuan** (**60.56%** YoY growth), net profit **191.12 million Yuan** (**30.23%** YoY growth), and net cash flow from operating activities **193.26 million Yuan** (**223.81%** YoY growth) - This semi-annual report is unaudited[7](index=7&type=chunk)[112](index=112&type=chunk) Consolidated Financial Statement Core Data (Unit: Yuan) | Item | June 30, 2022 / Jan-Jun 2022 | Dec 31, 2021 / Jan-Jun 2021 | | :--- | :--- | :--- | | **Balance Sheet** | | | | Total Assets | 2,633,812,405.96 | 2,505,486,058.34 | | Total Liabilities | 397,813,722.73 | 305,048,176.89 | | Total Owner's Equity Attributable to Parent Company | 2,235,998,683.23 | 2,200,437,881.45 | | **Income Statement** | | | | Total Operating Revenue | 665,368,135.42 | 414,393,998.89 | | Total Operating Costs | 464,880,432.42 | 264,582,729.56 | | Net Profit | 191,120,801.78 | 146,757,676.14 | | **Cash Flow Statement** | | | | Net Cash Flow from Operating Activities | 193,256,420.35 | 59,681,746.53 | | Net Cash Flow from Investing Activities | 32,575,774.64 | -144,946,564.93 | | Net Cash Flow from Financing Activities | -142,282,809.50 | -80,952,745.50 | [Taxation](index=73&type=section&id=VI.%20Taxation) The company's main taxes include VAT (**13%**) and Urban Maintenance and Construction Tax (**7%**), benefiting from a **15%** corporate income tax rate as a high-tech enterprise and a **13%** export tax refund rate - The company is recognized as a high-tech enterprise, valid for three years (2021-2023), enjoying a preferential corporate income tax rate of **15%**[241](index=241&type=chunk) - The company's export goods are subject to a tax exemption, offset, and refund management method, with a refund rate of **13%**[242](index=242&type=chunk) [Summary of Notes to Consolidated Financial Statements](index=74&type=section&id=VII.%20Notes%20to%20Consolidated%20Financial%20Statements) At period-end, trading financial assets totaled **1.24 billion Yuan**, primarily structured deposits and bank wealth management products, while construction in progress was **168 million Yuan**, mainly for phenyl intermediate and silicone resin projects - As of the end of the period, the company's trading financial assets balance was **1.24 billion Yuan**, primarily consisting of structured deposits and bank wealth management products[245](index=245&type=chunk) - The balance of construction in progress at period-end was **168 million Yuan**, primarily invested in the phenyl intermediate project (**140 million Yuan**) and the phenyl silicone resin project (**26 million Yuan**)[290](index=290&type=chunk) H1 2022 Operating Revenue Composition | Product Type | Operating Revenue (Yuan) | | :--- | :--- | | Functional Additives | 562,776,674.49 | | Phenylchlorosilane | 80,741,078.43 | | Other Businesses | 21,850,382.50 | | **Total** | **665,368,135.42** | - During the reporting period, the company's financial expenses were **-12.73 million Yuan**, primarily due to exchange gains of **11.65 million Yuan**[343](index=343&type=chunk) [Supplementary Information](index=129&type=section&id=XVIII.%20Supplementary%20Information) During the reporting period, the company's total non-recurring gains and losses amounted to **11.60 million Yuan**, with a weighted average return on net assets of **8.52%** and basic earnings per share of **0.85 Yuan** Return on Net Assets and Earnings Per Share | Profit for the Reporting Period | Weighted Average Return on Net Assets (%) | Basic Earnings Per Share (Yuan) | | :--- | :--- | :--- | | Net Profit Attributable to Common Shareholders of the Company | 8.52 | 0.85 | | Net Profit Attributable to Common Shareholders of the Company (Excluding Non-recurring Items) | 8.00 | 0.80 |